FDA Approved Products

1,302 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Active:Lifecycle: PeakClear all
REZUROCK
belumosudil
Peak
Sanofi
ORAL · TABLET
2021
NDA
0/100
REZZAYO
rezafungin acetate
Peak
INTRAVENOUS · POWDER
2023
NDA
0/100
RHOFADE
oxymetazoline hydrochloride
Peak
TOPICAL · CREAM
2017
NDA
0/100
RHOPRESSA
netarsudil
Peak
Alcon
OPHTHALMIC · SOLUTION/DROPS
2017
NDA
0/100
RINVOQ
upadacitinib
Peak
AbbVie
ORAL · TABLET, EXTENDED RELEASE
2019
SMNDA
0/100
RIOMET ER
metformin hydrochloride
Peak
Fosun Pharma
ORAL · FOR SUSPENSION, EXTENDED RELEASE
2019
NDA
0/100
ROCKLATAN
netarsudil and latanoprost ophthalmic solution, 0.02%/0.005%
Peak
Alcon
OPHTHALMIC · SOLUTION/DROPS
2019
NDA
0/100
ROSZET
ezetimibe; rosuvastatin calcium
Peak
ORAL · TABLET
2021
NDA
0/100
ROZLYTREK
entrectinib
Peak
Roche
ORAL · CAPSULE
detected by an FDA-approved testdetected by an FDA-approved test without a known acquired resistance mutation+2
2019
SMNDA
0/100
RUBRACA
rucaparib
Peak
Adienne Pharma and Biotech
ORAL · TABLET
2016
NDA
0/100
RYALTRIS
olopatadine hydrochloride and mometasone furoate
Peak
NASAL · SPRAY, METERED
2022
NDA
0/100
RYBELSUS
oral semaglutide
Peak
Novo Nordisk
ORAL · TABLET
2019
PeptideNDA
0/100
RYKINDO
risperidone
Peak
Luye Pharma
INTRAMUSCULAR · FOR SUSPENSION, EXTENDED RELEASE
2023
NDA
0/100
SAXENDA
liraglutide
Peak
Novo Nordisk
SUBCUTANEOUS · SOLUTION
2014
PeptideNDA
0/100
SCEMBLIX
asciminib
Peak
Novartis
ORAL · TABLET
2021
SMNDA
0/100
SCENESSE
afamelanotide
Peak
SUBCUTANEOUS · IMPLANT
2019
PeptideNDA
0/100
SECUADO
asenapine
Peak
TRANSDERMAL · SYSTEM
2019
NDA
0/100
SEGLENTIS
celecoxib; tramadol hydrochloride
Peak
Kowa Pharmaceuticals
ORAL · TABLET
2021
NDA
0/100
SELENIOUS ACID
selenious acid
Peak
INTRAVENOUS · SOLUTION
2019
NDA
0/100
SESQUIENT
fosphenytoin sodium
Peak
INTRAVENOUS · SOLUTION
2020
NDA
0/100
SEYSARA
sarecycline hydrochloride
Peak
Almirall
ORAL · TABLET
2018
NDA
0/100
SEZABY
phenobarbital sodium
Peak
PharmaIN
INTRAVENOUS · POWDER
2022
NDA
0/100
SINCALIDE
sincalide
Peak
MAIA Biotechnology
INTRAVENOUS · POWDER
2022
NDA
0/100
SINUVA
mometasone furoate
Peak
IMPLANTATION · IMPLANT
2017
NDA
0/100